Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Autoimmune Disorders

Free Subscription 23.12.2024 1 Ann Neurol 2 BMC Neurol 2 Brain 1 Curr Opin Immunol 6 Diabet Med 1 Diabetes 5 Diabetes Res Clin Pract 4 Intern Med 8 J Autoimmun 6 J Clin Endocrinol Metab 5 J Neuroimmunol 14 J Neurol 1 J Pediatr 1 J Rheumatol 3 Lancet Neurol 15 Mult Scler 1 Nat Rev Neurol 1 Neurologia (Engl Ed) 4 Neurology 4 PLoS One 3 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. HELBIG I, Ganesan S
   NORSE, FIRES, and a Polygenic Trickle of Autoimmunity.
   Ann Neurol. 2024 Dec 7. doi: 10.1002/ana.27148.
   PubMed        
   
   

   
   BMC Neurol

2. LI J, Zhang G, Zheng J, Hu J, et al
   A case report of neuronal intranuclear inclusion disease and literature review.
   BMC Neurol. 2024;24:488.
   PubMed         Abstract available
   
   
3. LIANG X, Zhang C, Xue J, Zheng Y, et al
   Efficacy of double filtration plasmapheresis in the treatment of steroid and/or IVIG unresponsive neuronal surface antibodies associated autoimmune encephalitis.
   BMC Neurol. 2024;24:475.
   PubMed         Abstract available
   
   

   
   Brain

4. COLES A
   A blood test to predict prognosis in multiple sclerosis?
   Brain. 2024;147:3969.
   PubMed        
   
   
5. ANDRODIAS G, Lunemann JD, Maillart E, Amato MP, et al
   De-escalating and discontinuing disease-modifying therapies in multiple sclerosis.
   Brain. 2024 Dec 21:awae409. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Curr Opin Immunol

6. HARM J, Fan YT, Brenner D
   Navigating the metabolic landscape of regulatory T cells: from autoimmune diseases to tumor microenvironments.
   Curr Opin Immunol. 2024;92:102511.
   PubMed         Abstract available
   
   

   
   Diabet Med

7. SOHOLM JC, Norgaard SK, Norgaard K, Clausen TD, et al
   Sensor-derived glycaemic metrics in pregnant women with type 1 diabetes randomised to faster acting insulin aspart or insulin aspart-A secondary analysis of the CopenFast trial.
   Diabet Med. 2024 Nov 4:e15467. doi: 10.1111/dme.15467.
   PubMed         Abstract available
   
   
8. SHULMAN R, Zenlea I, Ivers N, Austin PC, et al
   An audit and feedback-based intervention to improve diabetes management in the year after transfer to adult type 1 diabetes care: A multi-center quasi-experimental study.
   Diabet Med. 2024 Oct 29:e15444. doi: 10.1111/dme.15444.
   PubMed         Abstract available
   
   
9. COLLEY J, Hughes S, Dambha-Miller H, Price H, et al
   The diabetes annual review in a postal box: A qualitative study exploring the views of people living with diabetes (DiaBox-Qual).
   Diabet Med. 2024 Oct 21:e15445. doi: 10.1111/dme.15445.
   PubMed         Abstract available
   
   
10. WONG JY, Styles SE, Wiltshire EJ, de Bock MI, et al
    Experiences of adolescents and young adults with type 1 diabetes and chronically elevated glucose levels following the transition from multiple daily injections to advanced hybrid closed-loop: A qualitative study.
    Diabet Med. 2024 Oct 8:e15449. doi: 10.1111/dme.15449.
    PubMed         Abstract available
    
    
11. MOHR TC, de Wit M, Embaye J, Ehrmann D, et al
    Effectiveness of the MyDiaMate application in reducing diabetes distress in adults with type 1 diabetes: Study protocol of the multi-national, randomised-controlled MyREMEDY trial.
    Diabet Med. 2024 Sep 30:e15442. doi: 10.1111/dme.15442.
    PubMed         Abstract available
    
    
12. HASHIM R, Forde R, Parsons J, Ausili D, et al
    Qualitative study exploring the experiences of sexual dysfunction in premenopausal women with type 1 diabetes.
    Diabet Med. 2024 Sep 20:e15439. doi: 10.1111/dme.15439.
    PubMed         Abstract available
    
    

    
    Diabetes

13. MALLONE R, Sims E, Achenbach P, Mathieu C, et al
    Emerging concepts and success stories in type 1 diabetes research: a roadmap for a bright future.
    Diabetes. 2024 Oct 24:db240439. doi: 10.2337/db24-0439.
    PubMed         Abstract available
    
    

    
    Diabetes Res Clin Pract

14. STAHL-PEHE A, Baechle C, Lanzinger S, Kamrath C, et al
    Evaluation of spatiotemporal associations between COVID-19 pandemic waves and the incidence of pediatric type 1 diabetes in Germany considering time lags: A register-based ecological study.
    Diabetes Res Clin Pract. 2024;218:111936.
    PubMed         Abstract available
    
    
15. LUCKMANN SL, Forster A, Heinrich S, Buhtz C, et al
    Utilisation of blood glucose test strips in insulin-requiring people with diabetes mellitus using continuous glucose monitoring in Saxony-Anhalt - Analysis of health insurance data.
    Diabetes Res Clin Pract. 2024;218:111935.
    PubMed         Abstract available
    
    
16. MARI J, Solidoro S, Braida C, Tamaro G, et al
    Perceptions and understanding of family pediatricians regarding the new Italian Type 1 Diabetes screening program.
    Diabetes Res Clin Pract. 2024;218:111931.
    PubMed         Abstract available
    
    
17. ZHOU Y, Lei M, Yang D, Ling P, et al
    Real-world efficacy and safety of open-source automated insulin delivery for people with type 1 diabetes mellitus: Experience from mainland China.
    Diabetes Res Clin Pract. 2024;218:111910.
    PubMed         Abstract available
    
    
18. MARINO M, Boccolini G, Tombolini P, Tiberi V, et al
    A proposal for breakfast to improve the postprandial glucose response in children with type 1 diabetes - Preliminary results from a camp-based study.
    Diabetes Res Clin Pract. 2024;218:111881.
    PubMed         Abstract available
    
    

    
    Intern Med

19. OMIYA M, Morii Y, Mukai M, Mitsuhashi Y, et al
    Myasthenic Crisis and Concomitant Takotsubo Syndrome Complicated by Shock.
    Intern Med. 2024;63:3383-3387.
    PubMed         Abstract available
    
    
20. SUZUKI T, Orime K, Akamatsu R, Akiyama T, et al
    Type 1 Diabetes Mellitus with Diabetic Ketoacidosis Presenting with Transient Severe Fatty Liver and Subsequent Liver Dysfunction.
    Intern Med. 2024;63:3339-3344.
    PubMed         Abstract available
    
    
21. YASUBA H, Yamada H, Togo M, Matoba K, et al
    Subarachnoid Hemorrhaging with Multiple Cerebral Artery Stenoses after Initiating Remission Induction Therapy for Eosinophilic Granulomatosis with Polyangiitis.
    Intern Med. 2024;63:3389-3394.
    PubMed         Abstract available
    
    
22. IGARASHI S, Ogawa T, Kushibiki T, Ito K, et al
    Fatal C-Reactive Protein-less Sepsis with Anti-IL-6 Autoantibody Production after Administration of Durvalumab.
    Intern Med. 2024 Dec 19. doi: 10.2169/internalmedicine.4754.
    PubMed         Abstract available
    
    

    
    J Autoimmun

23. ZENG L, Li Y, Xiang W, Xiao W, et al
    Advances in chimeric antigen receptor T cell therapy for autoimmune and autoinflammatory diseases and their complications.
    J Autoimmun. 2024;150:103350.
    PubMed         Abstract available
    
    
24. MAZ MP, Reddy AL, Berthier CC, Tsoi LC, et al
    Lupus-prone NZM2328 mice exhibit enhanced UV-induced myeloid cell recruitment and activation in a type I interferon dependent manner.
    J Autoimmun. 2024;149:103296.
    PubMed         Abstract available
    
    
25. PENG X, Wang S, Wu K, Cook C, et al
    Effect of opioid receptor antagonist on mitigating tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-induced apoptolysis in pemphigus pathogenesis.
    J Autoimmun. 2024;149:103307.
    PubMed         Abstract available
    
    
26. EHRSTROM A, Jansson S, Jorgensen MH, Wewer V, et al
    The risk of cancer in pediatric-onset immune-mediated inflammatory diseases - A nationwide study.
    J Autoimmun. 2024;149:103321.
    PubMed         Abstract available
    
    
27. LONG H, Espinosa L, Sawalha AH
    Unraveling the immunomodulatory impact of hydroxychloroquine on peripheral T cells using single-cell RNA sequencing.
    J Autoimmun. 2024;149:103324.
    PubMed         Abstract available
    
    
28. BERTI A, Tomasi M, Pesce I, Lista E, et al
    Identification of the central tolerance checkpoint for autoreactive proteinase 3(+) B cells in human bone marrow.
    J Autoimmun. 2024;149:103330.
    PubMed         Abstract available
    
    
29. SORIN B, Papo M, Sinico RA, Teixeira VS, et al
    Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors.
    J Autoimmun. 2024;149:103338.
    PubMed         Abstract available
    
    
30. MAHDY AKH, Lokes E, Schopfel V, Kriukova V, et al
    Bulk T cell repertoire sequencing (TCR-Seq) is a powerful technology for understanding inflammation-mediated diseases.
    J Autoimmun. 2024;149:103337.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

31. HUANG J, Su A, Yang J, Zhuang W, et al
    Postmarketing Safety Concerns of Teprotumumab: A Real-World Pharmacovigilance Assessment.
    J Clin Endocrinol Metab. 2024;110:159-165.
    PubMed         Abstract available
    
    
32. MONTASER E, Farhy LS, Kovatchev BP
    Novel Detection and Progression Markers for Diabetes Based on Continuous Glucose Monitoring Data Dynamics.
    J Clin Endocrinol Metab. 2024 May 31:dgae379. doi: 10.1210.
    PubMed         Abstract available
    
    
33. SOOY MGQ, Pyle L, Alonso GT, Broncucia HC, et al
    Lower Prevalence of Diabetic Ketoacidosis at Diagnosis in Research Participants Monitored for Hyperglycemia.
    J Clin Endocrinol Metab. 2024 Mar 12:dgae158. doi: 10.1210.
    PubMed         Abstract available
    
    
34. XU Y, Liu R, Huang L, Qin Y, et al
    Comprehensive Comparisons of Different Treatments for Active Graves' Orbitopathy: A Systematic Review and Bayesian Model-Based Network Meta-Analysis.
    J Clin Endocrinol Metab. 2024 Dec 16:dgae877. doi: 10.1210.
    PubMed         Abstract available
    
    
35. RAZVI SS, Wild H, Ingoe L, Vernazza J, et al
    Changes in thyroid function and autoimmunity in older individuals: longitudinal analysis of the Whickham cohort.
    J Clin Endocrinol Metab. 2024 Dec 14:dgae875. doi: 10.1210.
    PubMed         Abstract available
    
    
36. HE X, Cao L, Fu X, Wu Y, et al
    The association between telomere length and diabetes mellitus: accumulated evidence from observational studies.
    J Clin Endocrinol Metab. 2024 Aug 1:dgae536. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

37. GURSKI CJ, Hajiyeva Z, Veltri AJ, Fenton K, et al
    Elevated frequencies of activated memory B cells in multiple sclerosis are reset to healthy control levels after B cell depletion with Ocrelizumab.
    J Neuroimmunol. 2024;399:578502.
    PubMed         Abstract available
    
    
38. LIANG Y, Huang J, Zhang X, Xu F, et al
    Quantitative assessment of thalamic damage and serum neurofilament light chain in relapsing-remitting multiple sclerosis.
    J Neuroimmunol. 2024;399:578504.
    PubMed         Abstract available
    
    
39. GILLIGAN M, O'Donnell L, Westbrook A, Tubridy N, et al
    A complex and severe encephalitis associated with four co-existing neuronal cell-surface autoantibodies.
    J Neuroimmunol. 2024;399:578501.
    PubMed         Abstract available
    
    
40. HERNANDEZ RUIZ JJ, Romero Malacara AMC, Lopez Mota LA, Perez Guzman MJ, et al
    Therapeutic development towards T follicular helper cells as a molecular target in myasthenia gravis disease.
    J Neuroimmunol. 2024;399:578503.
    PubMed         Abstract available
    
    
41. VORASOOT N, Halfdanarson TR, Madigan NN, Dubey D, et al
    Pre-existing Lambert-Eaton Myasthenic Syndrome and Scleroderma in a Patient with Neuroendocrine Carcinoma Undergoing Immune Checkpoint Inhibitor Cancer Immunotherapy.
    J Neuroimmunol. 2025;398:578485.
    PubMed         Abstract available
    
    

    
    J Neurol

42. FILIPPI M, Margoni M, Zaccone T, Guerrieri S, et al
    Disability worsening outcome in multiple sclerosis based on EDSS: does half a point matter?
    J Neurol. 2024;272:9.
    PubMed        
    
    
43. MARLET IR, Andersen RK, Axelsen KH, Andersen LK, et al
    Factors affecting the diagnostic delay of myasthenia gravis.
    J Neurol. 2024;272:29.
    PubMed         Abstract available
    
    
44. COMABELLA M, Hegen H, Villar LM, Rejdak K, et al
    Increased EBNA1-specific antibody response in primary-progressive multiple sclerosis.
    J Neurol. 2024;272:26.
    PubMed         Abstract available
    
    
45. GASPERINI C, Battaglia MA, Balzani F, Chiarini E, et al
    Unveiling preferences in multiple sclerosis care: insights from an Italian discrete-choice experiment with patients and healthcare professionals.
    J Neurol. 2024;272:27.
    PubMed         Abstract available
    
    
46. NICOLESCU M, Haussler V, Paul F, Oertel FC, et al
    Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and vision.
    J Neurol. 2024;272:86.
    PubMed         Abstract available
    
    
47. BARBA L, Gaetani L, Sperandei S, Di Sabatino E, et al
    CSF synaptic biomarkers and cognitive impairment in multiple sclerosis.
    J Neurol. 2024;272:85.
    PubMed         Abstract available
    
    
48. MIRMOSAYYEB O, Yazdan Panah M, Moases Ghaffary E, Vaheb S, et al
    Magnetic resonance imaging-based biomarkers of multiple sclerosis and neuromyelitis optica spectrum disorder: a systematic review and meta-analysis.
    J Neurol. 2024;272:77.
    PubMed         Abstract available
    
    
49. INAN B, Ozturk B, Ata N, Ulgu MM, et al
    A nationwide epidemiological study of myasthenia gravis in Turkey.
    J Neurol. 2024;272:5.
    PubMed         Abstract available
    
    
50. VECCHIO D, Puricelli C, Virgilio E, Passarelli F, et al
    Kappa index for multiple sclerosis diagnosis: an accurate biomarker of intrathecal synthesis.
    J Neurol. 2024;272:30.
    PubMed         Abstract available
    
    
51. PONZIO M, Santoni L, Molina M, Tavazzi E, et al
    Economic burden of multiple sclerosis in an Italian cohort of patients on disease-modifying therapy: analysis of disease cost and its components.
    J Neurol. 2024;272:50.
    PubMed         Abstract available
    
    
52. DE BLASIIS P, Massimiani A, Inglese C, Bianchini E, et al
    Spasticity patterns assessment and recognition for therapeutic approaches (SPARTA) in multiple sclerosis: a multicenter epidemiological study.
    J Neurol. 2024;272:34.
    PubMed         Abstract available
    
    
53. KLIMAS R, Sturm D, Altenborg A, Stylianou N, et al
    Assessing axonal pathology and disease progression in chronic inflammatory demyelinating polyneuropathy using corneal confocal microscopy.
    J Neurol. 2024;272:51.
    PubMed         Abstract available
    
    
54. BUGGE C, Engebretsen I, Kristiansen IS, Saether EM, et al
    Medical costs of treating myasthenia gravis in patients who need intravenous immunoglobulin (IVIg) - a register-based study.
    J Neurol. 2024;272:15.
    PubMed         Abstract available
    
    
55. FASANO C, Bettiol A, Vastola M, Lotti A, et al
    Effectiveness and safety of intravenous immunoglobulin for peripheral neuropathy in EGPA patients: a retrospective study.
    J Neurol. 2024;272:13.
    PubMed         Abstract available
    
    

    
    J Pediatr

56. HAKOLA L, Lundqvist A, Gissler M, Virta LJ, et al
    Prenatal and Postnatal Exposure to Antibiotics and the Risk of Type 1 Diabetes in Finnish children: A Register-Based Study.
    J Pediatr. 2024 Sep 6:114292. doi: 10.1016/j.jpeds.2024.114292.
    PubMed         Abstract available
    
    

    
    J Rheumatol

57. GONZALEZ-GAY MA, Castaneda S, Ferraz-Amaro I
    Managing Giant Cell Arteritis With Tocilizumab: Relapses and Adverse Events.
    J Rheumatol. 2024 Dec 15:jrheum.2024-1204. doi: 10.3899/jrheum.2024-1204.
    PubMed        
    
    

    
    Lancet Neurol

58. OLIVE-CIRERA G, Fonseca E, Chen LW, Fetta A, et al
    Differential diagnosis and comparison of diagnostic algorithms in children and adolescents with autoimmune encephalitis in Spain: a prospective cohort study and retrospective analysis.
    Lancet Neurol. 2025;24:54-64.
    PubMed         Abstract available
    
    
59. DALE RC
    Autoimmune encephalitis: diagnostic challenges and tensions.
    Lancet Neurol. 2025;24:5-6.
    PubMed        
    
    
60. AMATO MP, Portaccio E
    Multiple sclerosis in 2024: evolving evidence and new hopes.
    Lancet Neurol. 2025;24:17-18.
    PubMed        
    
    

    
    Mult Scler

61. MALLUCCI G, Zimmer A, Sfikas N, Cerda-Fuertes N, et al
    Neurostatus-SMARTCARE clinical trial: Enabling health care professionals to assess EDSS for decentralized trials in multiple sclerosis.
    Mult Scler. 2024 Dec 20:13524585241305966. doi: 10.1177/13524585241305966.
    PubMed         Abstract available
    
    
62. CHRISTENSEN R, Jolly A, Yam C, Yiannakas MC, et al
    Investigating the complementary value of OCT to MRI in cognitive impairment in relapsing-remitting multiple sclerosis.
    Mult Scler. 2024 Dec 20:13524585241304356. doi: 10.1177/13524585241304356.
    PubMed         Abstract available
    
    
63. KOCH MW, Camara-Lemarroy C, Strijbis E, Mostert J, et al
    Selecting Informative Patients for Phase 2 Progressive Trials in MS: Design Considerations for Phase 2 Clinical Trials in Progressive MS.
    Mult Scler. 2024;30.
    PubMed         Abstract available
    
    
64. CORREALE J, Marrodan M
    Live-attenuated vaccines for multiple sclerosis patients living in regions with endemic infections: A complex decision.
    Mult Scler. 2024 Dec 18:13524585241305956. doi: 10.1177/13524585241305956.
    PubMed         Abstract available
    
    
65. NYLANDER A, Sisodia N, Henderson K, Wijangco J, et al
    From "invisible" to "audible": Features extracted during simple speech tasks classify patient-reported fatigue in multiple sclerosis.
    Mult Scler. 2024 Dec 17:13524585241303855. doi: 10.1177/13524585241303855.
    PubMed         Abstract available
    
    
66. ONTANEDA D, Miron VE
    Breaking Barriers in Multiple Sclerosis.
    Mult Scler. 2024;30.
    PubMed        
    
    
67. VAN DAM M, Rottgering JG, Nauta IM, de Jong BA, et al
    Understanding the complex network of objectively assessed cognition and self-reported psychological symptoms in people with multiple sclerosis.
    Mult Scler. 2024 Dec 9:13524585241302173. doi: 10.1177/13524585241302173.
    PubMed         Abstract available
    
    
68. LANGER-GOULD A
    Racial and Ethnic Disease Phenotype Differences Are Driven by Genetics: No.
    Mult Scler. 2024;30.
    PubMed         Abstract available
    
    
69. BERGSLAND N, Dwyer MG, Zivadinov R
    Imaging the Choroid Plexus.
    Mult Scler. 2024;30.
    PubMed         Abstract available
    
    
70. MCGINLEY MP
    Improving Access to MS Care Through Technology.
    Mult Scler. 2024;30.
    PubMed         Abstract available
    
    
71. PILUTTI LA, Donkers SJ
    Exercise as a Therapeutic Intervention in Multiple Sclerosis.
    Mult Scler. 2024;30.
    PubMed         Abstract available
    
    
72. MOTL RW
    Randomized Controlled Trials of Rehabilitation in Multiple Sclerosis: Barriers and Unmet Needs.
    Mult Scler. 2024;30.
    PubMed         Abstract available
    
    
73. GAITAN MI, Marquez RV, Ayerbe J, Reich DS, et al
    Imaging Outcomes for Phase 2 Trials Targeting Compartmentalized Inflammation.
    Mult Scler. 2024;30.
    PubMed         Abstract available
    
    
74. KRYSKO KM
    Considerations for family planning in adolescent and young adults with multiple sclerosis.
    Mult Scler. 2024 Dec 7:13524585241303481. doi: 10.1177/13524585241303481.
    PubMed        
    
    
75. CHANG G, Stoney S, Narula S
    Pregnancy outcomes in adolescent and young adult patients with multiple sclerosis: A case series.
    Mult Scler. 2024 Dec 7:13524585241303490. doi: 10.1177/13524585241303490.
    PubMed         Abstract available
    
    

    
    Nat Rev Neurol

76. NESBITT C, Van Der Walt A, Butzkueven H, Cheung AS, et al
    Exploring the role of sex hormones and gender diversity in multiple sclerosis.
    Nat Rev Neurol. 2024 Dec 11. doi: 10.1038/s41582-024-01042.
    PubMed         Abstract available
    
    

    
    Neurologia (Engl Ed)

77. MIRELES-RAMIREZ MA, Velazquez-Brizuela IE, Sanchez-Rosales N, Marquez-Pedroza Y, et al
    The prevalence, incidence, and clinical assessment of neuromyelitis optica spectrum disorder in patients with demyelinating diseases.
    Neurologia (Engl Ed). 2024;39:743-748.
    PubMed         Abstract available
    
    

    
    Neurology

78. WONG SH, Abuzaitoun R, Cornblath WT, Eggenberger ER, et al
    Multicenter Validation of the Ocular Myasthenia Gravis Rating Scale Questionnaire.
    Neurology. 2025;104:e210150.
    PubMed         Abstract available
    
    
79. MONGAY-OCHOA N, Pareto D, Alberich M, Carbonell-Mirabent P, et al
    Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis.
    Neurology. 2025;104:e210136.
    PubMed         Abstract available
    
    
80. CHEN B, Francis A, Cooper SA, Dobson R, et al
    Quantitative Contribution of Clinical Attacks to Residual Disability in Patients With AQP4-Antibody Neuromyelitis Optica Spectrum Disorder.
    Neurology. 2025;104:e210137.
    PubMed         Abstract available
    
    
81. JUL JARBAEK NIELSEN J, Levison L, Andersen H
    Changes in Myasthenia Gravis Incidence in Denmark From 1985 to 2021: A Nationwide Population-Based Study.
    Neurology. 2025;104:e210139.
    PubMed         Abstract available
    
    

    
    PLoS One

82. DESCHAMPS N, Nacher M, Preux PM, Takam V, et al
    Pattern, causes and functional outcome of peripheral neuropathies in the Amazon region.
    PLoS One. 2024;19:e0315760.
    PubMed         Abstract available
    
    
83. SHRIWASH N, Aiman A, Singh P, Basir SF, et al
    Understanding the role of potential biomarkers in attenuating multiple sclerosis progression via multiomics and network-based approach.
    PLoS One. 2024;19:e0314428.
    PubMed         Abstract available
    
    
84. LEE JY, Lee SB, Yang SW, Paik JS, et al
    Linsitinib inhibits IGF-1-induced cell proliferation and hyaluronic acid secretion by suppressing PI3K/Akt and ERK pathway in orbital fibroblasts from patients with thyroid-associated ophthalmopathy.
    PLoS One. 2024;19:e0311093.
    PubMed         Abstract available
    
    
85. KOOSHKI A, Farmani R, Amirabadizadeh A, Mehrpour O, et al
    Essential and toxic metal concentrations in biological samples of multiple sclerosis patients: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0313851.
    PubMed         Abstract available
    
    

    
    Thyroid

86. RACHMASARI KN, Hamadi D, Thapa P, Bradley E, et al
    The Epidemiology of Thyroid Eye Disease in Olmsted County, Minnesota 2005-2020.
    Thyroid. 2024 Sep 16. doi: 10.1089/thy.2024.0304.
    PubMed         Abstract available
    
    
87. ZAJNER C, Patil N, McInnis R, Van Uum S, et al
    Patterns of Extraocular Muscle Enlargement in Graves' Orbitopathy and Acromegaly.
    Thyroid. 2024 Dec 20. doi: 10.1089/thy.2024.0438.
    PubMed         Abstract available
    
    
88. CHO YY, Kim B, Jin SM, Jung CH, et al
    Graves' Disease and the Risk of Type 2 Diabetes: A Korean Population-Based Study.
    Thyroid. 2024 Dec 20. doi: 10.1089/thy.2024.0270.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.